喉癌和鼻咽癌体外药敏试验AgNOR法的实验及临床研究

胡国华; 魏莲枝; 孙余才; 董蒲江; 朱江

doi:10.13406/j.cnki.cyxb.2003.02.016

您当前的位置：

首页 >

文章列表页 >

喉癌和鼻咽癌体外药敏试验AgNOR法的实验及临床研究

更新时间：2024-01-17

- 喉癌和鼻咽癌体外药敏试验AgNOR法的实验及临床研究
- Experimental and clinical study of in vitro chemosensitivity assay for laryngeal carcinoma and nasopharyngeal carcinoma by AgNOR methods
- 重庆医科大学学报 2003年第2期页码：172-174
- 作者机构：
  
  1. 重庆医科大学临床学院耳鼻咽喉科
  2. 重庆医科大学临床学院器官移植研究室
  3. 重庆医科大学临床学院耳鼻咽喉科,重庆,400016
- 作者简介：
- 基金信息：
  
  重庆市科委应用基础基金资助（渝科发计字 [2 0 0 2 ] 18号10 1）
- DOI：10.13406/j.cnki.cyxb.2003.02.016
  中图分类号： R739.65
- 纸质出版日期：2003，
扫描看全文
[1]胡国华,魏莲枝,孙余才,董蒲江,朱江.喉癌和鼻咽癌体外药敏试验AgNOR法的实验及临床研究[J].重庆医科大学学报,2003(02):172-174.

HU Guohua, et al. Experimental and clinical study of in vitro chemosensitivity assay for laryngeal carcinoma and nasopharyngeal carcinoma by AgNOR methods[J]. Journal of Chongqing Medical University, 2003,(2):172-174.
[1]胡国华,魏莲枝,孙余才,董蒲江,朱江.喉癌和鼻咽癌体外药敏试验AgNOR法的实验及临床研究[J].重庆医科大学学报,2003(02):172-174. DOI： 10.13406/j.cnki.cyxb.2003.02.016.

HU Guohua, et al. Experimental and clinical study of in vitro chemosensitivity assay for laryngeal carcinoma and nasopharyngeal carcinoma by AgNOR methods[J]. Journal of Chongqing Medical University, 2003,(2):172-174. DOI： 10.13406/j.cnki.cyxb.2003.02.016.

摘要

目的 :用嗜银蛋白检测技术（AgNOR）分析喉癌和鼻咽癌对 8种常用化疗药物的敏感性。方法 :从 5 6例喉癌和鼻咽癌患者获取新鲜肿瘤组织标本

采用单纯机械分离法制备单细胞悬液

加入抗癌药物后培养 36h

细胞悬液涂片、银染

计数银染颗粒后计算均值下降率 ;12例患者同期行化疗。结果 :5 1例肿瘤获得实验成功

可评价率为 91.1% ;AgNOR颗粒均值下降率从 0～ 6 3%

在 8种单一药物中

对DDP的敏感率最高

其它较为敏感的药物为VCR、5 -FU、PYM ;鼻咽癌对抗癌药物的敏感性显著高于喉癌对抗癌药物的敏感性 ;体外药敏与体内疗效的总符合率为 80 %。结论 :AgNOR技术简便易行

与临床相关性好

是一种有应用前景的体外药敏筛选方法。

Abstract

Objective: To evaluate in vitro chemosensitivity of laryngeal carcinoma and nasopharyngeal carcinoma to eight kinds of antineoplastic drugs by AgNOR technique. Methods: Fresh specimens of 56 cases were obtained from laryngeal carcinoma and nasopharyngeal carcinoma.We severed tumor tissue with simple mechanical separation method.After the acting of drugs

cell smear and argyrophilic staining

the mean inhibiting rate was calculated.10 cases were treated with chemotherapy at the same time. Results: 51 cases′specimens succeeded in the experiments

and the rate of success was 91.1%.The changes of mean inhibiting rate was from 0 to 63%.The chemosensitivity to DDP was the highest in eight kinds of antineoplastic drugs.Secondly

VCR

5-FU

and PYM were the highest.The sensitivity to drugs in laryngeal carcinoma was significantly higher than nasopharyngeal carcinoma.The coincidence between the experiment and clinic was 80%. Conclusion: AgNOR method is simple and convenient.In addition

it has clear correlation with the results of therapy.The method is useful for chemotherapy.

关键词

喉癌鼻咽癌体外药敏AgNOR

Keywords

laryngeal carcinomanasopharyngeal carcinomaIn vitro chemosensitivityAgNOR

references

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

1,25-二羟维生素D₃通过PI3K/AKT/Bcl-2信号通路诱导喉癌细胞Hep-2细胞凋亡

鼻咽癌喉癌患者血清唾液酸基转移酶岩藻糖基转移酶活性观察

放疗结合化疗治疗鼻咽癌114例分析

聚合酶链反应检测EB病毒DNA在鼻咽癌诊断中的应用

鼻咽癌的临床表现及误诊（附507例分析）